HK1073656A1 - Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent - Google Patents

Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent

Info

Publication number
HK1073656A1
HK1073656A1 HK05106161A HK05106161A HK1073656A1 HK 1073656 A1 HK1073656 A1 HK 1073656A1 HK 05106161 A HK05106161 A HK 05106161A HK 05106161 A HK05106161 A HK 05106161A HK 1073656 A1 HK1073656 A1 HK 1073656A1
Authority
HK
Hong Kong
Prior art keywords
guanidines
thia
phenanthrene
dihydro
carbonyl
Prior art date
Application number
HK05106161A
Other languages
English (en)
Inventor
Heinz-Werner Kleemann
Peter Below
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1073656A1 publication Critical patent/HK1073656A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/10Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK05106161A 2002-02-07 2005-07-21 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent HK1073656A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10204989A DE10204989A1 (de) 2002-02-07 2002-02-07 Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PCT/EP2003/000653 WO2003066620A1 (de) 2002-02-07 2003-01-23 Dihydro-thia-phenanthren-carbonyl-guanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum

Publications (1)

Publication Number Publication Date
HK1073656A1 true HK1073656A1 (en) 2005-10-14

Family

ID=27618378

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05106161A HK1073656A1 (en) 2002-02-07 2005-07-21 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent

Country Status (25)

Country Link
EP (1) EP1474414B1 (pt)
JP (1) JP4410564B2 (pt)
KR (1) KR20040096555A (pt)
CN (1) CN1319963C (pt)
AR (1) AR038393A1 (pt)
AT (1) ATE380805T1 (pt)
AU (1) AU2003208337A1 (pt)
BR (1) BR0307495A (pt)
CA (1) CA2475093A1 (pt)
CO (1) CO5601008A2 (pt)
DE (2) DE10204989A1 (pt)
HK (1) HK1073656A1 (pt)
HR (1) HRP20040721A2 (pt)
HU (1) HUP0402595A2 (pt)
MA (1) MA27171A1 (pt)
MX (1) MXPA04007476A (pt)
NO (1) NO20043717L (pt)
NZ (1) NZ534536A (pt)
PE (1) PE20030963A1 (pt)
PL (1) PL370271A1 (pt)
RS (1) RS69204A (pt)
RU (1) RU2306311C2 (pt)
TW (1) TWI268927B (pt)
WO (1) WO2003066620A1 (pt)
ZA (1) ZA200406015B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200614995A (en) 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60262887A (ja) * 1984-06-11 1985-12-26 Mitsubishi Chem Ind Ltd 液晶組成物
GB8505756D0 (en) * 1985-03-06 1985-04-11 Erba Farmitalia Tricyclic dibenzo condensed derivatives
US4948806A (en) * 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
DE19601303A1 (de) * 1996-01-16 1997-07-17 Boehringer Ingelheim Kg Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln
CA2370607A1 (en) * 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
DE10001879A1 (de) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
BR0307495A (pt) 2004-12-28
JP4410564B2 (ja) 2010-02-03
ATE380805T1 (de) 2007-12-15
HUP0402595A2 (hu) 2005-04-28
AR038393A1 (es) 2005-01-12
TWI268927B (en) 2006-12-21
RS69204A (en) 2006-12-15
CN1630649A (zh) 2005-06-22
NO20043717L (no) 2004-11-03
KR20040096555A (ko) 2004-11-16
CN1319963C (zh) 2007-06-06
TW200404792A (en) 2004-04-01
ZA200406015B (en) 2005-11-14
DE50308787D1 (de) 2008-01-24
MXPA04007476A (es) 2004-11-10
MA27171A1 (fr) 2005-01-03
CA2475093A1 (en) 2003-08-14
JP2005517015A (ja) 2005-06-09
DE10204989A1 (de) 2003-08-21
EP1474414B1 (de) 2007-12-12
HRP20040721A2 (en) 2005-06-30
WO2003066620A1 (de) 2003-08-14
AU2003208337A1 (en) 2003-09-02
PL370271A1 (en) 2005-05-16
CO5601008A2 (es) 2006-01-31
EP1474414A1 (de) 2004-11-10
PE20030963A1 (es) 2004-01-12
RU2004126854A (ru) 2006-01-27
RU2306311C2 (ru) 2007-09-20
NZ534536A (en) 2006-02-24

Similar Documents

Publication Publication Date Title
HUS1400056I1 (hu) Glükopiranozil-helyettesített benzol-származékok, az említett vegyületeket tartalmazó gyógyszerek, azok alkalmazása, és eljárás elõállításukra
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
HK1081965A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
HRP20050328A2 (en) Process for the preparation of (s,s)-cis-2-benzhyd
HK1076095A1 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
PL372690A1 (en) Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
HK1076460A1 (en) Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
PT1838683E (pt) Um processo para a preparação de derivados de [1,4,5]-oxadiazepina
IL150228A0 (en) Substituted norbornylamino derivatives, method for the production thereof, use thereof as medicament or a diagnostic reagent and medicaments containing said compounds
ZA200601001B (en) Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same
EP1561434A4 (en) BITE ATTACHMENT, BIT AND MANUFACTURING PROCESS THEREFOR
HK1073656A1 (en) Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
IL162562A (en) Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines
IL181556A0 (en) Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds
SI1513834T1 (sl) Substituirani tiofeni, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali kot diagnostik kot tudi zdravilo, ki jih vsebuje
HK1051853A1 (en) Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same.
PL363247A1 (en) Manipulator, particularly for medical purposes
SI1509498T1 (sl) Pentafluorosulfanil-benzoilgvanidini, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali diagnosticno sredstvo in zdravilo, ki jih vsebuje
MX260263B (es) Procedimiento para la preparacion de polieteroles.
SI1560826T1 (sl) Spojine piridopirimidinona, postopek za njihovo pripravo in farmacevtski sestavki, ki te vsebujejo
AU2003284212A8 (en) Process for the preparation of (s,s)-cis-2-phenyl-3-aminopiperidine
IL152735A0 (en) A predictive diagnostic indicator method, including variation electrocardiology examples

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAME OF THE INVENTOR FROM KILLMANN, HEINZ-WERNER TO KLEEMANN, HEINZ-WERNER

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110123